DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · IEX Real-Time Price · USD
1.000
+0.164 (19.62%)
At close: Jul 22, 2024, 8:42 AM
0.930
-0.070 (-7.01%)
Pre-market: Jul 22, 2024, 9:15 AM EDT
DBV Technologies Employees
As of December 31, 2023, DBV Technologies had 105 total employees, including 104 full-time and 1 part-time employees. The number of employees increased by 19 or 22.09% compared to the previous year.
Employees
105
Change (1Y)
19
Growth (1Y)
22.09%
Revenue / Employee
$142,305
Profits / Employee
-$757,238
Market Cap
80.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sangamo Therapeutics | 405 |
Protalix BioTherapeutics | 208 |
Chimerix | 72 |
BioAtla | 65 |
PMV Pharmaceuticals | 63 |
Ikena Oncology | 43 |
SCYNEXIS | 29 |
Genenta Science | 14 |
DBVT News
- 13 days ago - Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - GlobeNewsWire
- 6 weeks ago - DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - DBV Technologies Announces Plan to Implement ADS Ratio Change - GlobeNewsWire
- 7 weeks ago - DBV Technologies to Participate in Upcoming EAACI 2024 Congress - GlobeNewsWire
- 2 months ago - DBV Technologies Announces Results of its 2024 Combined General Meeting - GlobeNewsWire
- 2 months ago - DBV Technologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - DBV Technologies Reports First Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 3 months ago - Combined General Meeting of May 16, 2024 - GlobeNewsWire